Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Senators Ask Nominee to Support FDA Safety Review of Mifepristone After New Claims of Higher Adverse Events
3270660 · May 8, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
Summary
Senator Josh Hawley and others pressed Jim O'Neil to back a thorough FDA safety review of mifepristone following a large insurance-claims study; O'Neil said he supports a safety review and would back the secretary's work on the matter.
Senator Josh Hawley asked Jim O'Neil about a large insurance-claims study covering 865,727 mifepristone prescriptions from 2017 to 2023 that the senator said shows substantially higher rates of serious adverse events…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
30-day money-back on paid plans
